Systematic screening at diagnosis of-5/del(5)(q31),-7, or chromosome 8 aneuploidy by interphase fluorescence in situ hybridization in 110 acute myelocytic leukemia and high-risk myelodysplastic syndrome patients:: concordances and discrepancies with conventional cytogenetics

被引:36
作者
Beyer, V
Castagné, C
Mühlematter, D
Parlier, V
Gmür, J
Hess, U
Kovacsovics, T
Meyer-Monard, S
Tichelli, A
Tobler, A
Jacky, E
Schanz, U
Bargetzi, M
Hagemeijer, A
de Witte, T
van Melle, G
Jotterand, M [1 ]
机构
[1] CHU Vaudois, Unite Cytogenet Canc, Serv Genet Med, CH-1011 Lausanne, Switzerland
[2] Onkozentrum, Zurich, Switzerland
[3] Kantonsspital, Klin C Innere Med, St Gallen, Switzerland
[4] CHU Vaudois, Div Hematol, CH-1011 Lausanne, Switzerland
[5] Kantonsspital, CH-4031 Basel, Switzerland
[6] Inselspital Bern, Hamatol Zentrallabor, CH-3010 Bern, Switzerland
[7] Univ Zurich Hosp, CH-8091 Zurich, Switzerland
[8] Kantonsspital, Zentrum Onkol Hamatol, Aarau, Switzerland
[9] Univ Leuven, Dept Human Genet, Louvain, Belgium
[10] Univ Nijmegen, Med Ctr, Dept Hematol, Nijmegen, Netherlands
[11] Inst Univ Med Sociale & Prevent, Lausanne, Switzerland
关键词
D O I
10.1016/j.cancergencyto.2003.10.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To assess the contribution of interphase fluorescence in situ hybridization (I-FISH) toward the detection of recurring unbalanced chromosomal anomalies at diagnosis, a systematic screening of -5/del(5)(q31), -7, and chromosome 8 aneuploidy was performed on I 10 patients with acute myelocytic leukemia or high-risk myelodysplastic syndrome. We searched for monosomy 5/del(5q) by one-color I-FISH with a probe specific for the 5q31 region and for -7/+8 by dual-color I-FISH with centromeric probes for chromosomes 7 and 8. Discrepancies between conventional cytogenetics (CC) and I-FTSH were observed in 8 of the 110 patients (7.3%). For -5/del(5)(q3 1), a discordance was observed in two patients with complex abnormalities involving chromosome 5. Whereas no discordance was observed for -7, I-FISH detected a trisomy 7 unnoticed by CC in two cases. In six patients, I-FISH revealed a chromosome 8 aneuploidy not detected by CC. Our results illustrate that, when using this specific set of probes, I-FISH is of special interest for the detection of minor clones with chromosome 8 aneuploidy, breakpoint assessment, and sequence identification (markers). Also, to avoid misinterpretations, I-FISH should not be used alone at disease presentation, particularly in cases complex changes that have clearly established prognostic significance. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:29 / 41
页数:13
相关论文
共 60 条
  • [1] Fluorescent in situ hybridization (FISH) for the detection of trisomy 8 in acute myeloblastic leukemia
    Amiel, A
    Elis, A
    Manor, Y
    Tangi, I
    Fejgin, M
    Lishner, M
    [J]. LEUKEMIA & LYMPHOMA, 1996, 23 (5-6) : 603 - &
  • [2] Hidden monosomy 7 in acute myeloid leukemia and myelodysplastic syndrome detected by interphase fluorescence in situ hybridization
    Arif, T
    Tanaka, K
    Damodaran, C
    Asou, H
    Kyo, T
    Dohy, H
    Kamada, N
    [J]. LEUKEMIA RESEARCH, 1996, 20 (09) : 709 - 716
  • [3] 3 NEW CASES OF CHROMOSOME-3 REARRANGEMENT IN BAND-Q21 AND BAND-Q26 WITH ABNORMAL THROMBOPOIESIS BRING FURTHER EVIDENCE TO THE EXISTENCE OF A 3Q21Q26-SYNDROME
    BELLOMO, MJ
    PARLIER, V
    MUHLEMATTER, D
    GROB, JP
    BERIS, P
    [J]. CANCER GENETICS AND CYTOGENETICS, 1992, 59 (02) : 138 - 160
  • [4] BENNETT JM, 1982, BRIT J HAEMATOL, V51, P189, DOI 10.1111/j.1365-2141.1982.tb08475.x
  • [5] PROPOSED REVISED CRITERIA FOR THE CLASSIFICATION OF ACUTE MYELOID-LEUKEMIA - A REPORT OF THE FRENCH-AMERICAN-BRITISH COOPERATIVE GROUP
    BENNETT, JM
    CATOVSKY, D
    DANIEL, MT
    FLANDRIN, G
    GALTON, DAG
    GRALNICK, HR
    SULTAN, C
    [J]. ANNALS OF INTERNAL MEDICINE, 1985, 103 (04) : 620 - 625
  • [6] Bernasconi P., 2003, Leukemia Research, V27, pS53
  • [7] Is monosomy 5 an uncommon aberration?: Fluorescence in situ hybridization reveals translocations and deletions in myelodysplastic syndromes or acute myelocytic leukemia
    Bram, S
    Swolin, B
    Rödjer, S
    Stockelberg, D
    Ögärd, I
    Bäck, H
    [J]. CANCER GENETICS AND CYTOGENETICS, 2003, 142 (02) : 107 - 114
  • [8] Fluorescence in situ hybridization confirmation of 5q deletions in patients with hematological malignancies
    Brezinová, J
    Zemanová, Z
    Cermák, J
    Michalová, K
    [J]. CANCER GENETICS AND CYTOGENETICS, 2000, 117 (01) : 45 - 49
  • [9] BRIZARD F, 1994, LEUKEMIA, V8, P1005
  • [10] Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia:: results from Cancer and Leukemia Group B (CALGB 8461)
    Byrd, JC
    Mrózek, K
    Dodge, RK
    Carroll, AJ
    Edwards, CG
    Arthur, DC
    Pettenati, MJ
    Patil, SR
    Rao, KW
    Watson, MS
    Koduru, PRK
    Moore, JO
    Stone, RM
    Mayer, RJ
    Feldman, EJ
    Davey, FR
    Schiffer, CA
    Larson, RA
    Bloomfield, CD
    [J]. BLOOD, 2002, 100 (13) : 4325 - 4336